Medicines for HER2+ breast cancer

RX_HER2PLUS

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L01XC03|L01XC14|L01XE45

-

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

-

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

-

diagram downward connector

Include endpoints None

-

diagram downward connector
RX_HER2PLUS

Extra metadata

First used in FinnGen datafreeze DF5

Similar endpoints

List of similar endpoints to Medicines for HER2+ breast cancer based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
?
Number of individuals
- - -
?
Unadjusted prevalence (%)
- - -
?
Mean age at first event (years)
- - -

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_HER2PLUS – Medicines for HER2+ breast cancer
GWS hits:

Survival analyses between endpoints

Plot

before Medicines for HER2+ breast cancer
after Medicines for HER2+ breast cancer

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Medicines for HER2+ breast cancer